Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European CountriesVictoria Divino, Matthew Reaney, Shawn Hallinan et al.|Diabetes Therapy|2014Cited by 41